1. Does CJC-1295 and ipamorelin work?
Each raises growth hormone and IGF-1 in healthy adults; that is proven. Whether the combination does anything to your muscle, fat, sleep, or recovery has never been measured in a human study. The closest controlled evidence, a two-year trial of an oral ghrelin mimetic, found about a kilogram of extra lean mass and no change in strength.
2. What is the right CJC-1295 ipamorelin dosage?
There is no validated dose. The community convention is 100 to 300 mcg of each, one to three times a day, on an empty stomach, with the bedtime injection considered essential. The only trial doses on record are a hospital IV dose of ipamorelin for bowel recovery and weekly injections of the long-acting DAC form, neither of which resembles the stack.
3. Should I use CJC-1295 with DAC or without DAC with ipamorelin?
The community uses the no-DAC form, on the theory that a short GHRH signal plus a short ghrelin signal gives a natural pulse rather than a week-long elevation. The human data all belong to the DAC form; the no-DAC form has never been studied in people. Whichever you pick, you are choosing between a molecule with a small evidence base and one with none.
4. What results should I expect, and how long does it take?
Nobody can tell you from data, because no study has measured results. The “before and after” posts online are uncontrolled and usually come with a training and diet change. The hormone response is immediate; any body-composition change from a GH-axis drug, where it has been measured with other compounds, takes months and is modest.
5. Is CJC-1295 ipamorelin the best peptide for muscle growth?
No peptide has good human evidence for muscle growth in healthy adults. Among the GH-axis options, tesamorelin has the strongest trial record, at about 1.4 kg of lean mass in people with HIV lipodystrophy. For a healthy person the evidence does not identify a “best,” because none of them has been shown to work for that purpose.
6. Is CJC-1295 + ipamorelin legal or FDA approved?
Neither is approved anywhere in the world. In the US, the FDA’s advisory committee voted 0 to 12 against ipamorelin in October 2024 and 0 to 13 against CJC-1295 in December 2024, so neither can lawfully be compounded, and neither was among the peptides freed from Category 2 in April 2026. Possession is not a crime for an individual in most jurisdictions, but the vials are unapproved drugs and both compounds are banned in sport.
7. Can a telehealth clinic or compounding pharmacy prescribe CJC/ipamorelin?
A doctor can write anything on a prescription pad, but a US pharmacy has no lawful basis to fill it, because neither compound is an approved-drug ingredient, has a USP monograph, or is on the 503A bulks list. State boards of pharmacy, Ohio’s among them, have suspended pharmacies for doing exactly this. A pharmacy label on the vial does not change the substance’s status.
8. What are the side effects of CJC-1295 ipamorelin?
Hunger, headache, flushing, water retention, tingling hands, sleepiness after the dose, and injection-site redness are the common ones. In the CJC-1295 DAC trials, headache affected 63% of volunteers and diarrhoea 43%. The concerns worth blood tests are rising fasting glucose and IGF-1. The concerns nobody has data on are long-term cancer risk and the pituitary DNA-damage finding.
9. Does ipamorelin make you hungry or gain fat?
It can. Ipamorelin acts on the ghrelin receptor, and ghrelin is the hunger hormone. In the only controlled comparison against growth hormone, in mice, ipamorelin increased body fat, leptin, and food intake. The year-long human trial of a different ghrelin mimetic recorded increased appetite and a 2.7 kg weight gain. If your goal is fat loss, the pharmacology is working against you.
10. How does CJC/ipamorelin compare with tesamorelin/ipamorelin?
Tesamorelin is a full-length GHRH analogue with two Phase 3 trials and an FDA approval for visceral fat in HIV lipodystrophy, so the GHRH half of that stack has real evidence behind it. The ipamorelin half is the same in both stacks, with the same absent evidence and the same lost vote. No study has tested either combination.
Conclusion
CJC-1295 + Ipamorelin has a clear mechanism, but the evidence boundaries are equally clear. Understanding these common answers helps make more rational judgments.